Evolent Health, Inc.

EVH

Explore Our Financial Data > Companies > > Evolent Health, Inc.

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker	EVH
CIK	0001628908
SIC	8741
Sector	Services
Industry Category	Business Services
Industry Group	Services – Management, Public Relations, Consulting

Contact

Address	1812 NORTH MOORE ST, SUITE 1705, ARLINGTON, VA, 22209
Website	evolenthealth.com
Phone	571-389-6000
CEO	Seth B. Blackley
Employees	5,100

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement

Revenue	$2.40 billion
Pre-Tax Income	$-109.47 million
Net Income	$-108.96 million
Net Income to Common	$-140.48 million
EPS	$-1.22

View All

Balance Sheet

Cash	$246.55 million
Assets	$2.65 billion
Liabilities	$1.52 billion
Common Equity	$935.52 million
Liabilities & Equity	$2.65 billion

View All

Cash Flow Statement

Net Income	$-108.96 million
Cash From Operating Activities	$18.42 million
Cash From Investing Activities	$-66.29 million
Cash From Financing Activities	$92.41 million
Change in Cash	$44.37 million

View All

Calculations

NOPAT	$-20.09 million
EBITDA	$40.71 million
Price to Earnings	N/A
Price to Book	$1.09
ROE	-9.24%

View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

3 Russell 2000 Stocks Facing Headwinds

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.

Article Link

Q1 Rundown: Omnicell (NASDAQ:OMCL) Vs Other Healthcare Technology for Providers Stocks

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Omnicell (NASDAQ:OMCL) and the rest of the healthcare technology for providers stocks fared in Q1.

Article Link

EVH Q1 Earnings Call: Oncology Navigation Launch and AI Automation Drive Strategic Focus

Healthcare solutions company Evolent Health (NYSE:EVH) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 24.4% year on year to $483.6 million. Revenue guidance for the full year exceeded analysts’ estimates, but next quarter’s guidance of $455 million was less impressive, coming in 9.4% below expectations. Its non-GAAP profit of $0.06 per share was 33% below analysts’ consensus estimates.

Article Link

Healthcare Technology for Providers Stocks Q1 Teardown: Astrana Health (NASDAQ:ASTH) Vs The Rest

Looking back on healthcare technology for providers stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Astrana Health (NASDAQ:ASTH) and its peers.

Article Link

3 Stocks Under $10 in the Doghouse

Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying businesses are cheap, and we advise caution as many have questionable fundamentals.

Article Link